BRIEF published on 07/03/2024 at 05:05, 5 months ago MedMira Reports Third Quarter Results FY2024 Financial Results MedMira Q3 FY2024 Reveal® G4 Distribution Partners
PRESS RELEASE published on 07/03/2024 at 05:00, 5 months ago MedMira Reports Third Quarter Results FY2024 MedMira Inc. reports Q3 FY2024 financial results including revenue, gross profit, operating expenses, net loss, and balance sheet highlights. Company focuses on US FDA approved HIV test and new clinical trials in Canada Financial Results Clinical Trials MedMira Inc. Q3 FY2024 HIV Test
BRIEF published on 05/01/2024 at 04:05, 7 months 2 days ago MedMira nomme un nouveau vice-président du développement commercial Stratégie De Croissance MedMira Développement Des Affaires Rene Bell Marché Américain De La Santé
BRIEF published on 05/01/2024 at 04:05, 7 months 2 days ago MedMira Appoints New Vice President of Business Development Growth Strategy Business Development MedMira Rene Bell US Healthcare Market
PRESS RELEASE published on 05/01/2024 at 04:00, 7 months 2 days ago MedMira Announces the Hire of Vice President of Business Development MedMira Inc. expands commercialisation team, appoints Rene Bell as Vice President of Business Development. Bell to focus on sales growth and partnerships in the US market Sales Business Development US Market MedMira Inc. Rene Bell
BRIEF published on 04/02/2024 at 04:35, 8 months 1 day ago MedMira rend compte des résultats financiers et de l'évolution de l'activité du deuxième trimestre de l'exercice 2024 Résultats Financiers Hausse Des Revenus Autorisation De La FDA MedMira Santé Canada
BRIEF published on 04/02/2024 at 04:35, 8 months 1 day ago MedMira Reports on Q2 FY2024 Financial Results and Business Developments Financial Results Revenue Growth FDA Clearance Health Canada MedMira
PRESS RELEASE published on 04/02/2024 at 04:30, 8 months 1 day ago MedMira Reports Second Quarter Results FY2024 MedMira Inc. reports Q2 FY2024 financial results & milestones achieved including US FDA 510(k) clearance for Reveal® G4 Rapid HIV-1/2 test Financial Results MedMira Inc. Q2 FY2024 US FDA 510(k) Reveal® G4 Rapid HIV-1/2
BRIEF published on 03/13/2024 at 21:35, 8 months 20 days ago MedMira reçoit un brevet canadien pour un système de diagnostic innovant Innovation En Matière De Soins De Santé MedMira Brevet Canadien Système De Diagnostic Technologie RVF
BRIEF published on 03/13/2024 at 21:35, 8 months 20 days ago MedMira Receives Canadian Patent for Innovative Diagnostic System Healthcare Innovation MedMira Canadian Patent Diagnostic System RVF Technology
Published on 12/03/2024 at 18:00, 11 minutes ago RE Royalties Provides $6.3 Million Financing for a 200 Megawatt Solar Project in Alberta, Canada
Published on 12/03/2024 at 17:45, 26 minutes ago CannapharmaRX Updates on Alberta Facility Progress and International Export Strategy
Published on 12/03/2024 at 16:36, 1 hour 35 minutes ago Coast2Coast First Aid and Aquatics Celebrates 10 Years Anniversary with 100 Free CPR Training for Marginalized Communities
Published on 12/03/2024 at 16:00, 2 hours 11 minutes ago Ascend Aesthetic Partners Marks First Year Uniting Top Surgeons in Aesthetic Care Nationwide
Published on 12/03/2024 at 15:45, 2 hours 26 minutes ago MacDonald Mines Announces Letter of Intent with Canuc Resources Corporation
Published on 12/03/2024 at 18:00, 11 minutes ago MyHotelMatch: Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres
Published on 12/03/2024 at 17:45, 26 minutes ago Kudelski IoT and PUFsecurity Combine IoT Security Strengths to Meet the Challenges of Increasing Global Regulation
Published on 12/03/2024 at 16:41, 1 hour 29 minutes ago TAKKT AG: Andreas Weishaar appointed as Chief Executive Officer of TAKKT AG
Published on 12/03/2024 at 18:00, 11 minutes ago Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 12/03/2024 at 18:00, 11 minutes ago Covivio - Information on total number of voting rights and share capital
